Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > CritiTech and AAIPharma Services Announce Strategic Alliance

Abstract:
Alliance to Provide A Novel Drug Delivery Option to Pharmaceutical and Biotech Companies

CritiTech and AAIPharma Services Announce Strategic Alliance

Lawrence, KS & Willmington, NC | Posted on July 10th, 2010

AAIPharma Services Corp., a biopharmaceutical drug product development and contract manufacturing company, and CritiTech, Inc., a nanotechnology company that improves the delivery of therapeutic molecules, announce a strategic alliance to expand the reach of the CritiTech technology.

This alliance will allow pharmaceutical and biotech companies to choose a novel drug delivery option in early animal toxicology and clinical studies where there is a drug delivery challenge that cannot be solved through conventional approaches. Drug product development and manufacturing will be performed by AAIPharma Services, and drug product intermediate manufacturing will be performed by CritiTech. The two companies will be connected through AAIPharma Services' best-in-class project management expertise.

AAIPharma Services Corp already offers both its own proprietary drug delivery technologies as well as other technologies through its alliance partners, such as Emisphere Inc. The alliance with CritiTech provides a new drug delivery option for parenteral administration to complement AAIPharma Services already established oral drug delivery franchise. CritiTech's technology aims to improve the delivery of therapeutic molecules with low aqueous solubility or poor bioavailability. The key benefit of the CritiTech technology is the body's improved ability to absorb these difficult to formulate drugs. One key differentiator of the Crititech technology is it allows for parenteral administration of drugs which previously could not be administered via this route.

Chief Executive Officer of CritiTech Inc. David Johnston said "The Alliance with AAI Pharma services allows us to share the established CritiTech technology, used in our Nanotax™ product currently in development, with a broad range of potential customers. The collaboration with AAI Pharma services and their outstanding product development and manufacturing capability allows us to provide additional drug delivery options throughout the drug product development cycle and to more fully exploit CritiTech technology."

Chief Executive Officer of AAIPharma's Services L. Lee Karras added, "The alliance with CritiTech allows us to add a breakthrough drug delivery option for our pharmaceutical and biotech customers, whether they are developing a new product or improving an existing product already on the market. The combination of the CritiTech technology and AAIPharma Service's best- in- class drug product development and contract manufacturing services will be of tremendous value to customers. This new offering is in line with our strategy to become the leading provider of complex drug development services to the pharmaceutical and biotechnology industries."

####

About AAIPharma Services
AAIPharma Services Corp. is a leading provider of services that encompass the entire process of pharmaceutical drug development from discovery through commercialization. The company specializes in analytical chemistry, formulation development, clinical packaging, oral drug delivery and contract manufacturing. AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies throughout North America. It is headquartered in Wilmington, North Carolina. For more information on the company, go to www.aaipharma.com.

About CritiTech Technologies, Inc.
CritiTech is a technology company that focuses on a unique and improved delivery of therapeutic molecules and compounds using its patented nanotechnology. CritiTech’s technology is licensed from the Department of Chemical Engineering at the University of Kansas and the Higuchi Biosciences Center. The technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, vaginal or transdermal. CritiTech laboratory operations are located in Lawrence, Kansas. For more information on the company, go to www.crititech.com.

For more information, please click here

Contacts:
Media contacts:
AAIPharma Services .
Barry Johnson
800.575.4224, 919.260.6696


CritiTech Technologies, Inc
Davd Johnston Ph.D.
910.508.7994

Copyright © AAIPharma Services

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A big leap toward tinier lines: Self-assembly technique could lead to long-awaited, simple method for making smaller microchip patterns March 27th, 2017

“Cysteine Rose” Wins 2016 Thermo Fisher Scientific Electron Microscopy Image Contest: Thermo Fisher honors Andrea Jacassi of the Italian Institute of Technology for image of cysteine crystals using focused ion beam techniques March 27th, 2017

Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Nanomedicine

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Researchers make flexible glass for tiny medical devices: Glass can bend over and over again on a nanoscale March 27th, 2017

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Nanobiotix: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma March 23rd, 2017

Announcements

A big leap toward tinier lines: Self-assembly technique could lead to long-awaited, simple method for making smaller microchip patterns March 27th, 2017

“Cysteine Rose” Wins 2016 Thermo Fisher Scientific Electron Microscopy Image Contest: Thermo Fisher honors Andrea Jacassi of the Italian Institute of Technology for image of cysteine crystals using focused ion beam techniques March 27th, 2017

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017

Nanobiotechnology

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Nanobiotix: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma March 23rd, 2017

Nanoparticle paves the way for new triple negative breast cancer drug March 20th, 2017

Alliances/Trade associations/Partnerships/Distributorships

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017

AIM Photonics Welcomes Coventor as Newest Member: US-Backed Initiative Taps Process Modeling Specialist to Enable Manufacturing of High-Yield, High-Performance Integrated Photonic Designs March 16th, 2017

Applied Graphene Materials plc - Significant commercial progress in AGM’s three core sectors March 3rd, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project